PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
+19.43%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$2.97B
AUM Growth
+$2.97B
Cap. Flow
-$158M
Cap. Flow %
-5.33%
Top 10 Hldgs %
46.1%
Holding
105
New
9
Increased
22
Reduced
25
Closed
10

Top Buys

1
IMVT icon
Immunovant
IMVT
$49.6M
2
ARGX icon
argenx
ARGX
$40.1M
3
APGE icon
Apogee Therapeutics
APGE
$38.9M
4
RVMD icon
Revolution Medicines
RVMD
$36.6M
5
TNGX icon
Tango Therapeutics
TNGX
$27.2M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$74M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$68.3M
3
VIR icon
Vir Biotechnology
VIR
$48M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
$40M
5
ILMN icon
Illumina
ILMN
$27.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KRON
76
DELISTED
Kronos Bio
KRON
$2.28M 0.08%
1,752,745
– –
FBRX icon
77
Forte Biosciences
FBRX
$138M
$2.16M 0.07%
+130,614
New +$2.16M
SLRN
78
DELISTED
ACELYRIN
SLRN
$2.03M 0.07%
200,000
– –
SYRE icon
79
Spyre Therapeutics
SYRE
$1.02B
$994K 0.03%
+81,116
New +$994K
VBIV
80
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$926K 0.03%
1,381,355
– –
OMIC
81
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$900K 0.03%
78,774
– –
VERU icon
82
Veru
VERU
$48.5M
$784K 0.03%
108,988
+100,000
+1,113% +$719K
LPTX icon
83
Leap Therapeutics
LPTX
$12M
$62.1K ﹤0.01%
44,971
-541,762
-92% -$748K
MOTS
84
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$40.5K ﹤0.01%
6,002
– –
CMAXW
85
DELISTED
CareMax, Inc. Warrant
CMAXW
$11.3K ﹤0.01%
60,000
– –
EQRXW
86
DELISTED
EQRx, Inc. Warrant
EQRXW
$10K ﹤0.01%
250,000
– –
SRZNW icon
87
Surrozen, Inc. Warrant
SRZNW
$71.9K
$6.67K ﹤0.01%
166,666
– –
ACRS icon
88
Aclaris Therapeutics
ACRS
$223M
– –
0
– –
APLS icon
89
Apellis Pharmaceuticals
APLS
$3.51B
– –
-812,037
Closed -$74M
ARQT icon
90
Arcutis Biotherapeutics
ARQT
$1.91B
– –
0
– –
BMRN icon
91
BioMarin Pharmaceuticals
BMRN
$11.3B
– –
-263,207
Closed -$22.8M
BTAI icon
92
BioXcel Therapeutics
BTAI
$52.7M
– –
0
– –
ETNB icon
93
89bio
ETNB
$1.37B
– –
0
– –
EYPT icon
94
EyePoint Pharmaceuticals
EYPT
$827M
– –
0
– –
ILMN icon
95
Illumina
ILMN
$15.2B
– –
-149,060
Closed -$27.2M
NVAX icon
96
Novavax
NVAX
$1.2B
– –
0
– –
QTRX icon
97
Quanterix
QTRX
$202M
– –
-130,000
Closed -$2.93M
VIR icon
98
Vir Biotechnology
VIR
$765M
– –
-1,958,264
Closed -$48M
VKTX icon
99
Viking Therapeutics
VKTX
$3.02B
– –
-441,147
Closed -$7.15M
XBI icon
100
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
1 2 3
4
5